Cadernos de Saúde Pública (Feb 2015)

Impact of 10-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children up to two years of age in Brazil

  • Indianara Maria Grando,
  • Camile de Moraes,
  • Brendan Flannery,
  • Walter Massa Ramalho,
  • Marco Aurélio P. Horta,
  • Diana Lucia Moura Pinho,
  • Gilmara Lima Nascimento

DOI
https://doi.org/10.1590/0102-311X00169913
Journal volume & issue
Vol. 31, no. 2
pp. 276 – 284

Abstract

Read online

The objective of this study was to analyze the impact of vaccination against Streptococcus pneumoniae on the morbidity and mortality from pneumococcal meningitis in children ≤ 2 years in Brazil, from 2007 to 2012. This is a descriptive study and ecological analysis using data from the Information System on Notifiable Diseases. Pre-vaccination (2007-2009) and post-vaccination (2011-2012) periods were defined to compare incidence rates and mortality. A total of 1,311 cases and 430 deaths were reported during the study period. Incidence decreased from 3.70/100,000 in 2007 to 1.84/100,000 in 2012, and mortality decreased from 1.30/100,000 to 0.40/100,000, or 50% and 69% respectively, with the greatest impact in the 6-11 month age group. This decrease in Pneumococcal meningitis morbidity and mortality rates two years after introduction of the 10-valent pneumococcal conjugate vaccine suggests its effectiveness.

Keywords